(Q51061497)

PubMed publication ID

23599149

28 March 2018

http://europepmc.org/abstract/MED/23599149

title

ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Olga Balagué

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Elías Campo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

author name string

Alexandra Valera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Lluis Colomo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Antonio Martínez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Daphne de Jong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Gabriel Matheu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Mónica Martínez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Lekidelu Taddesse-Heath

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

Carlos E Bacchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

publication date

19 April 2013

1 reference

PubMed publication ID

23599149

28 March 2018

http://europepmc.org/abstract/MED/23599149

published in

Modern Pathology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

page(s)

1329-1337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.73

13 May 2020

exact match

0 references

cites work

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

The anaplastic lymphoma kinase in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Inhibition of ALK signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

ALK-positive diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Anaplastic lymphoma kinase in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Germinal centres: role in B-cell physiology and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Plasma cell differentiation requires the transcription factor XBP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.73

Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors

21 January 2018

1 reference

12 December 2020

ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases

1 reference

12 December 2020

A Case of a Diffuse Large B-Cell Lymphoma of Plasmablastic Type Associated With the t(2;5)(p23;q35) Chromosome Translocation

1 reference

12 December 2020

ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement

1 reference

12 December 2020

ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas

1 reference

12 December 2020

CD30-negative diffuse large B-cell lymphoma expressing ALK

1 reference

12 December 2020

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24

1 reference

12 December 2020

ALK-positive diffuse large B-cell lymphoma: report of three cases

1 reference

12 December 2020

Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity

1 reference

12 December 2020

Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features

1 reference

12 December 2020

Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation

1 reference

12 December 2020

IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas

1 reference

12 December 2020

Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements

1 reference

12 December 2020

A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation

1 reference

12 December 2020

Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.

1 reference

12 December 2020

A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation

1 reference

12 December 2020

10.1038/MODPATHOL.2013.73

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json

13 May 2020

PubMed publication ID

23599149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6368829&resulttype=core&format=json